VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 1 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,974 | -0.9% | 23,850 | +42.4% | 0.00% | +100.0% |
| Q3 2022 | $3,000 | -80.0% | 16,750 | -1.5% | 0.00% | -85.7% |
| Q2 2022 | $15,000 | -25.0% | 17,000 | +3.8% | 0.01% | +133.3% |
| Q1 2022 | $20,000 | -37.5% | 16,370 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $32,000 | – | 16,370 | +0.7% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 16,250 | +21.4% | 0.00% | -100.0% |
| Q2 2021 | $42,000 | – | 13,380 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,736,283 | $14,553,000 | 6.80% |
| VR Adviser, LLC | 16,047,286 | $19,899,000 | 3.22% |
| COMMODORE CAPITAL LP | 10,097,229 | $12,521,000 | 2.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,951,423 | $6,140,000 | 0.87% |
| EPIQ PARTNERS, LLC | 1,161,350 | $1,440,000 | 0.77% |
| NEA Management Company, LLC | 16,302,596 | $20,215,000 | 0.58% |
| Nicholas Investment Partners, LP | 4,570,387 | $5,667,000 | 0.40% |
| Ghost Tree Capital, LLC | 1,315,154 | $1,631,000 | 0.35% |
| Orbimed Advisors | 12,909,283 | $16,008,000 | 0.26% |
| HighVista Strategies LLC | 315,880 | $392,000 | 0.25% |